| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | Director | Common Stock | 2K | $1.8K | $0.90 | Oct 17, 2024 | Direct |
| Sorrento Therapeutics, Inc. | Director | Stock option (right to buy) | 250K | Aug 30, 2021 | Direct | ||
| Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 100K | Mar 15, 2024 | Direct | ||
| Silence Therapeutics plc | Director | Share Option (Right to Buy) | 48K | Jan 2, 2025 | Direct | ||
| Silence Therapeutics plc | Director | Ordinary Shares | 7.53K | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLN | Silence Therapeutics plc | Jan 2, 2025 | 1 | $0 | 4 | Jan 6, 2025 | Director |
| SLN | Silence Therapeutics plc | Jan 2, 2025 | 0 | $0 | 3 | Jan 2, 2025 | Director |
| SCLX | Scilex Holding Co | Oct 17, 2024 | 1 | $1.8K | 4 | Oct 18, 2024 | Director |
| SCLX | Scilex Holding Co | Mar 15, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
| SCLX | Scilex Holding Co | Jan 17, 2023 | 1 | $0 | 4 | Jan 17, 2023 | Director |
| SCLX | Vickers Vantage Corp. I | Nov 10, 2022 | 0 | $0 | 3 | Nov 15, 2022 | Director |
| SRNEQ | Sorrento Therapeutics, Inc. | Aug 30, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Director |